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Lipids under stress – a lipidomic
approach for the study of mood
disorders
Andre Miguel Miranda1)2) and Tiago Gil Oliveira1)2)
The emerging field of lipidomics has identified lipids as key
players in disease physiology. Their physicochemical
diversity allows precise control of cell structure and
signaling events through modulation of membrane prop-
erties and trafficking of proteins. As such, lipids are
important regulators of brain function and have been
implicated in neurodegenerative and mood disorders.
Importantly, environmental chronic stress has been
associatedwith anxiety and depression and its exposure in
rodents has been extensively used as a model to study
these diseases. With the accessibility to modern mass-
spectrometry lipidomic platforms, it is now possible to
snapshot the extensively interconnected lipid network.
Here, we review the fundamentals of lipid biology and
outline a framework for the interpretation of lipidomic
studies as a new approach to study brain pathophysiology.
Thus, lipid profiling provides an exciting avenue for the
identification of disease signatures with important impli-
cations for diagnosis and treatment of mood disorders.
Keywords:.brain; chronic stress; l ipid; l ipidomics; mass
spectrometry; mood disorders
Introduction
Lipids constitute a diverse group of molecules that are
fundamental for the structural organization and signaling
regulation of cells. Their vast physicochemical diversity
reflects their multiple functions at the cellular level, from
modulation of the chemical and mechanical properties of
membranes to protein trafficking, ion channel functioning
and cell-to-cell communication [1]. While the research areas of
genomics and proteomics have been extensively explored in
the past few years, the study of the lipidome has been lagging
behind essentially due to technical limitations. The recent
improvement in analytical techniques, such as mass spec-
trometry (MS)-based lipidomics, currently allows a compre-
hensive study of the lipid profile of different systems, from
cells to tissues or whole organisms, in an attempt to
understand the role of lipids in physiology and pathological
signaling events [2].
The study of lipids is particularly challenging, for lipid
structure is immensely varied and lipid species can be
dynamically interchangeable. The classical definition of a
lipid is a molecule soluble in organic solvents. However,
certain lipids present such a polarity that they are easily
diffused in the aqueous phase when performing organic
solvent-based lipid extraction [3]. Consequently, a thorough
qualitative and quantitative analysis of the lipidome of a
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system requires different analytical approaches directed to
each subset of lipid classes [4].
Considering the overwhelming structural diversity of
lipids and their role as putative modulators of different
aspects of cellular functioning, a tight regulation of its
metabolic pathways, both in space and time, is fundamental.
Since lipids make up to half of the brain’s dry weight, it is not
surprising that lipid imbalances are involved in the patho-
physiology of different neurodegenerative diseases [5–7].
Indeed, the recent use of MS has allowed the characterization
of large-scale changes in lipid profiles both in humans and
in animal models of disease [8–10]. This approach has
been complemented by studies with genetically modified
mice to better understand the role of specific lipids in health
and disease [11]. Moreover, the identification of lipidomic
signatures as biomarkers for diagnosis and therapeutical
responses is an emerging field of study [2].
In this review, we discuss new lipid analytical strategies to
study brain pathophysiology in the context of chronic stress
and of diseases for which stress is a recognized trigger, such
as anxiety and depression [12]. These novel experimental
approaches will allow a better understanding of patho-
physiological processes and the potential identification of
surrogate markers of disease. We outline new ways of
interpreting lipidomic data in a disease context and discuss
new technical and conceptual challenges for the future.
Understanding the complexity of the
brain lipidome
Lipids are crucial structural and functional components of
the brain, regulating membrane assembly, vesicle synthesis
and trafficking, neurotransmitter release, and signaling
propagation [13]. Despite the implication of different lipids
in various brain pathologies, mostly through studies
focusing on their metabolizing enzymes, we still lack a
comprehensive characterization of the brain lipidome and
how it is affected by disease. Indeed, a recent MS-based
lipidomic study analyzed the composition of different brain
regions and non-neural tissues of humans and other animal
species and concluded that concentration of lipids in the
brain evolved faster when compared to non-neural tissues,
with particular acceleration in the cortex [14]. This faster
divergence privileges a specific lipid organization of the
brain and reinforces the role of lipids in cognition and brain
physiology.
Given this plethora of functions, one can be challenged
by how lipids are structured and how they relate to other
molecules. In mammalian cells, the main lipid categories
are sterols (such as cholesterol), glycerophospholipids,
and sphingolipids (Fig. 1). Lipids are subdivided on the
basis of their chemical structure, namely a hydrophobic tail
and a polar head group. The hydrocarbon chain moiety
can vary in length, saturation, and hydroxylation, while
polar head groups can differ in shape and charge [15].
Theoretically, thousands of lipids may co-exist within the
same system and allow cells to organize their internal
constituents in discrete organelles, with particular identities
and functions. For instance, the assembly of highly organized
lipids in the plasma membrane promotes the existence of
a rigid and impermeable barrier between the intra- and
extracellular interface, in contrast with the flexible nature
of the endoplasmic reticulum (ER), required for biogenic
functions, such as synthesis and shuttling of lipids as
part of secretory vesicles [16]. These features ultimately
determine protein localization, conformation, and function.
Finally, since lipids are highly interconvertible molecules
and act as substrates to different lipid-modifying enzymes,
hydrolytic enzymes are able to breakdown structural
membrane components into second messengers [1]. While
the hydrophobic product (e.g. diacylglycerol (DG)) is typically
sequestered in the membrane of the parent molecule and
potentially acts as an anchor signal for protein kinases,
the polar structure (e.g. inositol 3-phosphate) is released
into the cytoplasm and available to bind receptors and
propagate intracellular signaling events, such as signal-
induced calcium release [17]. The result of such dynamism is
a complex crosstalk between structural components and
regulators of cell signaling.
Cholesterol is the most abundant lipid in the
brain
Cholesterol is mainly present in myelin sheaths and plasma
membranes [18]. There, it resides with other lipid categories
in constant molar ratios, namely glycerophospholipids and
sphingolipids, such that impairment of this lipid balance is
associated with disease [11]. Remarkably, delivery of periph-
eral lipoproteins across the blood-brain barrier is limited,
requiring the cholesterol content of the brain to be mostly
dependent on de novo synthesis and shuttling between
glial cells and neurons [19, 20]. Despite its enrichment in
membranes, cholesterol also plays a role in signaling, serving
as a precursor to active steroids, such as glucocorticoids
(GCs) [11]. These active molecules act as hormones, and differ
from protein signaling factors in the sense that they do not
typically bind to membrane receptors but rather diffuse
across membranes and complex with cytoplasmic/nuclear
receptors [21].
Cholesterol plays an important role in membranar lipid
packing and raft assembly, which has implications in protein
trafficking and folding. As a result, sterol levels are tightly
regulated. Excess free cholesterol is converted to cholesteryl
esters by the enzyme cholesterol acyltransferase 1 (ACAT 1)
for storage in lipid droplets or shuttling to the extracellular
milieu [22]. Alternatively, cholesterol conversion to 24S-
hydroxycholesterol is the most efficient mechanism for efflux
from the brain [23]. While the isoform 27S-hydroxycholesterol
can be incorporated in the brain from the periphery, its levels
are comparatively low and presents a very active metabolism,
hence its contribution to cholesterol homeostasis and brain
function is not yet very clear [24–26]. Additionally, mamma-
lian cells have a feedback system in which release of the
transcript factor SREBP2 from the ER under sterol depletion,
followed by cleavage in the Golgi apparatus and migration
through nuclear pores, activates sterol synthesis, and uptake
machinery [27].
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Figure 1. Examples of representative classes of the major lipid categories in mammalian cells. A: Cholesterol is the most abundant sterol in
mammals. It contains an inflexible four-ring core that confers high hydrophobicity and interferes with acyl packing in membranes, promoting
the assembly of lipid microdomains. Cholesterol plays an important role on the physical properties of membranes, namely fluidity, thickness,
and permeability. Enzymes, such as ACAT1 and cholesterol 24-hydroxylase, whose activities determine the rate of cholesterol efflux from the
brain to periphery, tightly regulate its levels. B: Glycerophospholipids are divided in classes according to the nature of the head group linked
to the glycerol backbone. These vary in shape and charge, determining their location within membranes in cells. The insight boxes show the
site of cleavage by phospholipases A2, C, and D. The respective products contribute to changes in membrane properties, such as induction
of curvature (lysoPC and PA), or act as intracellular signaling molecules (fatty acyls and DG). C: Sphingolipids contain a sphingoid backbone,
which is acylated to form a ceramide. Addition of polar head groups, phosphate or sugars, yields more complex classes, such as
phosphosphingolipids and gangliosides. Note the similarity of the building blocks from both categories, suggesting putative steps of crosstalk
between lipid metabolizing pathways. Colors: blue and green, fatty-acyl chain; orange, oligosaccharide chain; purple, sphingosine; red,
choline; yellow, phosphate group. Lipid structures adapted from LIPID MAPS [114].
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Glycerophospholipids are both structural and
signaling molecules
Glycerophospholipids rank amongst the most abundant lipids
in cells and serve as membrane components and signaling
molecules. Their structure is based on a glycerol backbone
linked to a polar head group at the position sn3 and one or two
fatty-acyl substituents present at sn1 and sn2 positions
(Fig. 1B). Examples of different subclasses are phosphatidyl-
choline (PC), phosphatidylserine (PS), and phosphatidylino-
sitol (PI), which differ among themselves by the addition of a
phosphocholine, phosphoserine, or a phosphoinositol ring as
head groups, respectively. Further glycerol units – up to two –
can be added to synthesizemore complex phospholipids, such
as bismonoacylglycerophosphate and cardiolipin [15].
The category of glycerophospholipids is a great example of
how physicochemically related lipids differ in abundance and
localization. For instance, PC is one of the most common
glycerophospholipid subclasses in cells and it is a major
component of cellular membranes, given its spontaneous
propensity to self-assemble in stable bilayer membranes [16].
PS is also abundant in cell membranes and, because of its
negatively charged head group, it plays an important role in
determining membrane surface charge in the inner leaflet of
membranes [28]. In regard to this specific example of non-
random distribution of phospholipids, apoptotic pathways
can be modulated by the inhibition of translocases and
activation of scramblases that induce a randomization of the
transbilayer gradient, resulting in external exposure of PS and
clearance of apoptotic bodies by phagocytes [29, 30]. More-
over, other less abundant glycerophospholipids, such as
phosphoinositides (PIs), have been reported to provide an
identity code to membrane compartments with amajor impact
in protein recruitment and signaling pathways [31]. Similarly
to sterols, glycerophospholipids also display feedback control
mechanisms that can respond to specific changes in lipid
concentration or physicochemical properties of membranes,
such as curvature stress [16].
Sphingolipids regulate the assembly of
membrane domains
Sphingolipids differ from the previous lipid category in the
substitution of the glycerol backbone by sphingosine. They
can be subdivided into sphingosine derivatives, ceramides
(Cer) (with the addition of a fatty acid), and more complex
sphingolipids with phosphate or carbohydrate head groups.
Glycosphingolipids are classified based on the charge and
number of carbohydrate head groups [15]. The simplest of
these have a single moiety linked to Cer (glucosyl- or
galactosylceramide), but more complex structures called
gangliosides include oligosaccharide chains containing sialic
acid groups [32].
Given their long and saturated fatty acid chains,
sphingolipids present a tall, straight, and narrow cylindrical
shape. This feature allows the assembly of highly ordered
solid-gel phase membrane domains, named by some authors
as lipid rafts, structures of higher complexity than initially
predicted by the fluid-mosaic model [33]. These detergent-
resistant membrane domains are also enriched in cholesterol,
which facilitates lateral association and mobility, and
modulates membrane thickness, with implications for protein
recruitment and sorting [11, 34].
Lipid metabolic networks are intrinsically
connected
Understanding the dynamics behind lipid diversity is an
essential step to unveil their biological function and
relevance. Most de novo lipid synthesis takes place in the
ER [35]. Here, phospholipids and sterols are produced and
shuttled to the Golgi and plasmamembrane through secretory
vesicles or pipelines orchestrated by lipid transfer proteins
[36, 37]. In the case of sphingolipids, the Cer backbone is
synthesized and transported from the ER to the Golgi
apparatus where it is then converted to sphingomyelin (SM)
by sphingomyelin synthases (SMS). Consistently, sterols
preferably accumulate in the Golgi where stabilization with
long, saturated acyl chains of SM and derivatives afford
protection of the hydrophobic core from the cytosol [38]. The
gradient of sterol and sphingolipids along the secretory
pathway is conserved by the exclusion of both from coat
protein I vesicles that retrogradely transport proteins
and lipids back to the ER [39]. Additionally, some lipid
metabolizing enzymes show different affinities for fatty acyls
and generate distinctive lipid subspecies with a unique fatty
acyl length and saturation, e.g. ceramide synthases and
phospholipases A. These may present distinct subcellular
localizations, and therefore mediate specific functions [40].
Moreover, some lipids present concentrations of different
order of magnitude such that minor disturbances in their
levels may result in larger impacts in their relative counter-
parts, within the same lipid category, e.g. relatively small
fluctuations in SM and PC breakdown may result in two or
more fold-change increases in Cer or PA, respectively [40]. The
crosstalk between metabolic pathways of distinct lipid
categories, such as the step mediating SM synthesis from the
transfer of the polar head group from the glycerophospholipid
PC to the sphingolipid Cer, adds another level of complexity
to the integrated system of lipid metabolism [40]. These points
of connection between multiple-lipid pathways may allow a
small disturbance in a specific metabolic branch to propagate
to other lipid categories. Such phenomena impair the overall
lipid shape equilibrium, in which the interplay between the
abundance of each lipid species and acyl chain composition
are tightly controlled to ensure the appropriate membrane
properties for organelle function. For a more detailed
discussion ofmembrane sensing, cross-talk and compensatory
mechanisms between lipid pathways, see [16, 41].
Lipids determine the properties of
membranes—from shape to function
Eukaryotic cells have evolved to form a complex membrane
system that allows compartmentalization of the cell into
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different organelles, where specific cellular functions occur,
such as post-translational modification and maturation of
proteins, spatial and temporal sorting, degradation, and
recycling of long-lived compounds and damaged organelles
[31]. Consistent with their functional complexity relatively to
prokaryotes is the sophistication of their lipidomes [42].
Although lipid classes are generally defined by their polar
head group, the fatty acids linked to their backbone may still
vary in lengthandsaturation, increasing thenumberofpossible
subspecies of lipids within the same class exponentially.
We have discussed that different lipids present different
shapes and biochemical behaviors when assembled together
in the same membranes. In general, the length of a
phospholipid is proportional to the number of carbon atoms
and inversely proportional to the degree of saturation
(presence of double bonds). Taking into consideration the
geometry of their polar head, lipids can assume different
shapes, such as cylindrical or conical forms. These changes in
geometry predict the shape of membranes, inducing planar or
curved structures, respectively. Interestingly, a cylindrical
phospholipid such as PC can be rapidly catabolized into
conical lipids, through hydrolysis to diacylglycerol (DG)
or phosphatidic acid (PA), by phospholipase C (PLC) and
phospholipase D (PLD), respectively, or converted in an
inverted-conical lysophosphatidylcholine (lysoPC) through
the release of a fatty acyl chain by phospholipase A (PLA).
Accordingly, cells defective in PS upregulate the similarly
charged and shaped PI as a compensatory mechanism and
another example of possible functional redundancy arises
from the similarity between conical phosphatidylethanol-
amine (PE) and PA [16].
It is, therefore, possible for a membrane to assume
different physical properties through the modulation of its
lipids, namely thickness, fluidity, raft assembly, or surface
charge [43]. Experimental evidence suggests that enrichment
of sterols in the plasma membrane, in addition to saturated
lipids, causes an increase in its thickness comparatively to
other compartments, such as the ER. Not only the trans-
membrane domains (TMD) of plasma membrane proteins are
longer than those located in the ER, but also proteins with
smaller TMD are more easily segregated from this compart-
ment when cholesterol is added, suggesting a model of
hydrophobic matching [44].
Another key feature of membranes is the propensity
to form microdomains, such as lipid rafts [6]. These lipid rafts
were reported to be particularly enriched in cholesterol and
sphingolipids with long and saturated fatty acids, a feature
allowing an ordered sorting and interdigitation of their
long chains between both leaflets [45]. These specific lipid
microdomain structures function as specialized docks for
localized cellular processes and have an important impact
in disease physiology [5, 46]. Consistently, perturbation of
sphingolipid metabolism results in altered protein compart-
mentalization through loss of assembly of these domains [43].
However, lipid rafts are not exclusively packed with
sphingolipids and sterols but also contain glycerophospho-
lipids, such as PC, its degree of recruitment being dependent
on its level of saturation [34]. Indeed, sphingolipid depletion
is compensated by synthesis of highly ordered and cylindrical
saturated phospholipids [41]. Such planar structures allow a
more ordered state and the likelihood to be recruited and
included in rafts. Additionally, the extent of phospholipid
saturation determines membrane adsorption of cytosolic
proteins by allowing packing defects that anchor hydrophobic
motifs [47].
Altogether, manipulation of membrane composition
regulates protein trafficking and folding and adjust flexibility
to ease the mechanical forces exerted by proteins, such as to
induce membrane curvature to facilitate vesicle fusion for
neurotransmitter release or vesicle budding for synaptic
vesicle recycling [48, 49].
Lipid imbalance is a hallmark of the
stressed brain
In modern societies, the exposure to environmental stress
is an increasing challenge. While physiological mechanisms
to respond to acute stress are fundamental for the survival of
an organism, the continuous or prolonged exposure to stress
stimuli can have a deleterious impact. This maladaptive
response includes functional and morphological impairment
in various brain regions, such as the hippocampus and the
prefrontal cortex (PFC). Consequently, chronic stress affects
brain functions, such as learning and memory, decision
making, emotional responses, and underlies the pathophysi-
ology of various brain disorders, namely anxiety, depression
and Alzheimer’s disease (AD) [50–57].
The response to chronic stress involves a fast activation of
the sympathetic nervous system, followed by a slower
activation of the hypothalamic-pituitary-adrenal axis that
culminates in the release of glucocorticoids (GCs), such as
cortisol in primates and corticosterone (CORT) in rodents. GCs
are believed to mediate a significant part of the pathologic
effects of chronic stress and lead to structural and functional
hippocampal impairment, with remarkable behavioral per-
turbations [52, 58–60]. Considering the multifaceted role of
lipids in brain function, their implication in stress-related
disorders, such as major depression and anxiety, is not
surprising [61]. In fact, lipid-modifying enzymes have been
reported to act downstream of GC signaling pathways and to
be subject of modulation by antidepressant treatment [62, 63].
Dietary intake of lipids, namely poly-unsaturated fatty
acids (e.g. docosahexaenoic acid (DHA)) affects the brain
lipid composition in a region specific manner and impacts
behavior [64–67]. Glycerolipid metabolism has been impli-
cated in the pathology of depression, from increased turnover
of phospholipids to single nucleotide polymorphisms in
related enzymes that confer higher risk for bipolar disorder
[68]. Increased sphingolipid breakdown and Cer production
has also been linked to depressive-like behavior and neuro-
inflammation, and has been postulated as a pharmacological
target of tricyclic antidepressants [61, 62]. Multiple studies
suggest a connection between aberrant lipid metabolism
and the neurobiology of depression through deregulation
of monoaminergic transmission or neurogenesis [68]. In
addition, indirect pathways may occur, such as lipid
deficiency-induced inflammation and aberrant lipid transport
from the periphery to the brain [69, 70].
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Taken together, certain specific lipid classes may be directly
implicated in brain disorders. Considering the impact of
dietary lipid intake and pharmacological intervention in brain
lipid metabolism, it was thus timely and informative to
conduct a comprehensive lipidomic profile of the brain under
conditions of stress.
Lipidomic analysis of the chronic-
stressed brain
In order to understand the impact of chronic stress exposure
on the rat brain lipidome, we employed a detailed MS-based
lipidomic analysis of different brain regions from animals
submitted to a 4-week chronic unpredictable stress paradigm
(Table 1) [12, 53]. In the next sections, we detail a basic
framework to conduct a lipidomic study and dissect the
metabolic implications for lipid signaling from this patho-
logical context.
Snapshotting lipid pathways
A possible initial approach to characterize the lipidome of a
system is to analyze the abundance of lipid categories
referenced to a control group. Given the diverse biochemical
properties of themammalian lipidome, particularly in terms of
polarity, different extraction methods need to be employed for
a full characterization. The use of a modified Bligh and Dyer
method allows an efficient and reproducible lipid extraction of
the major lipid classes soluble in organic solvents [71]. After
extraction, lipid classes are identified by a combined liquid
chromatography-mass spectrometry approach and quantified,
in molar values, by spiking with appropriate internal
standards. With such a broad analysis, it is possible to
integrate multiple lipid metabolic pathways and denote
whether changes in a lipid class are in concert with levels
of metabolically related products and whether any compen-
satory mechanisms are activated in a diseased setting.
While the present method is successful for the isolation
of most lipid species, accurate measurement of highly
polarized lipids (e.g. complex gangliosides) is hampered by
their retention in the aqueous phase or need for alternative
extraction methods for their purification [72]. Complementing
strategies, such as high-performance liquid chromatography
or the use of isotope-tagged derivatives, are required for the
characterization of low-abundant lipids and isoform specific
phospholipids, e.g. PI(3)P and PI(4)P [73–75]. Even though
the use of the present tools only allows the identification of
high-order relative fold changes, it has proven successful in
the collection of a macro-snapshot of the lipid molecular
species involved in disease pathology [8, 76].
Despite the common practice of using tissue homogenates
in lipidomic approaches to identify lipid alterations in brain
disorders, it is important to consider that whole tissue is
composed of multiple cell types, such as neuronal and glial
cells, each of which harbors its own lipid composition,
enhancing the level of complexity of interpreting large-scale
data sets [8, 63, 77, 78]. Indeed, we found significant
differences between the lipid compositions of the different
brain regions assessed [12]. Consequently, regional cellular
heterogeneity is a potential major contribute for lipid disparity
among different brain regions. Alternative approaches to
complement this tissue analysis include the use of micro-
dissection techniques or in vitro cell-type specific studies.
Ultimately, a complete spatial characterization of the cell
lipidome would require the analysis of the composition of
particular organelles or more spatially defined structures in
the central nervous system, through different biochemical
fractionation and purification methods [79, 80]. This would
be of particular relevance considering that bulk lipids
determine the physical properties of membranes, modulate
cellular protein machinery, and influence organelle function-
ality. The increase in spatial resolution can also be addressed
by imaging lipid distribution in frozen brain sections using
matrix-assisted laser desorption/ionization – time of flight/
mass-spectrometry imaging (MALDI-TOF/MSI) [81, 82]. Never-
theless, the cost for topographical specificity is the reduced
number of lipid species able to be identified, comparatively to
other more established MS methods. Finally, the set-up of
pulse and chase experiments in vitro, combined with the use
of fluorescently tagged lipid binding domains, caged lipids, or
direct labeling of lipids (e.g. deuterated lipids), can provide
unique information about their exact location and how
dynamically they change positions [83–86].
Knowing lipids from the inside: Fatty-acyl profile
and metabolizing enzymes
The structural diversity of lipid classes impacts membrane
function and interaction with the surrounding environment.
This is of particular importance in brain functioning and
neuronal processes. Neuronal communication relies on
complex mechanisms mediating chemical synapses, from
neurotransmitter release to sensing and signal initiation
and propagation. Lipids are involved not only in synaptic
vesicle fusion, and thus neurotransmitter release, but also
in the activity of neurotransmitter receptors, ion channel
Table 1. Changes in rat brain lipid composition induced by
chronic unpredictable stress exposure [12].
Brain region Lipid changes
Prefrontal
cortex
Decrease in glycerophospholipids (PC, PCe,
PE)
Increase in lysophospholipids (lysoPCa,
lysoPE)
Decrease in sphingolipids (SMa and dhSM)
Increase in sphingomyelin derivatives (Cer,
LacCer)
Hippocampus Decrease in PC
Increase in PI
Decrease in SM
Increase in sphingomyelin derivatives (Cer,
dhSM)
Amygdala Increase in sulfatide derivatives (Sulf(2OH))
Cerebellum No significant changes
aLipid changes correlated with serum CORT levels (R2> 0.4)
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conductivity, and intracellular signaling cascades [87–89].
Another level of complexity on top of the diversity of lipid
heads, that define each lipid class, is the variability of the
carbon chain length and degree of saturation of the fatty acyls
that ultimately determine the membrane biophysical proper-
ties [90]. These include lipid packing, fluidity and propensity
to raft assembly. While in MS lipid ions are identified by their
mass/charge ratio, such analysis is not directly informative
about their fatty-acyl composition other than the total number
of carbons and saturated bonds in the molecule. Therefore, to
determine the nature of the fatty acids in a specific lipid, it is
necessary to fragment lipids and detect the resulting products,
yielding a head group and one or two fatty acids, whether it is
a lyso- or phospholipid, respectively [43]. We have recently
characterized the profile of the fatty-acyl chains of phospho-
lipids, sphingolipids, and other neutral lipids in different
brain regions and how these are affected by the exposure to
chronic stress. In addition to a generalized increase in
glycerophospho- and sphingolipid hydrolysis, we reported a
decrease in shorter fatty-acyl phospholipids/DG in the PFC and
an increase in 38 carbon and four-double bond phospholipids/
DG in the hippocampus [12]. This accumulation of longer,
unsaturated species suggests the incorporation of arachidonic
acid (AA) – with the following “number of carbons”:”double
bonds” composition – 20:4 – as part of the fatty acyl
composition. AA is a known mediator of inflammation, is
positively correlated with age-induced changes and has also
been described to be enriched in a different rat model of
depressive-like behavior [91, 92]. In contrast, diets rich in
polyunsaturated fatty acids, such as fish oil diet, show an
increase in short, unsaturated DHA-containing phospholipids,
which are proposed to be neuroprotective and anxiolytic [93,
94]. Of note, patients with depression were found to have
an altered ratio of n-6/n-3 polyunsaturated fatty acids in
peripheral blood and these changes may reflect an altered
brain lipid composition, considering these fatty acids are also
used as substrates in brain lipid synthesis [95–98].
Another piece of relevant information obtained from
depicting lipid subspecies is the possible modulation of their
metabolic enzymes. Some lipid modifying enzymes have been
extensively implicated in brain disorders and proposed to be
modulated at the level of protein expression as well as
phosphorylation status [99–101]. Given the observed increase
in glycerophospholipid and sphingolipid breakdown after
exposure to chronic stress, we quantified the mRNA levels of
the lipid enzymesmost likely to underlie the observed findings
(Fig. 2). We found no changes in the transcript levels of several
PLA2, PLD, and sphingomyelinase isoforms [12]. These results
suggest a complex and yet to be identified mechanism of post-
transcriptional lipid enzyme regulation, which could involve
altered protein synthesis, post-translational modifications,
altered trafficking, or enzymatic activity.
Specific lipid imbalances are correlated with
biological mediators of chronic stress
Depression and anxiety disorders are examples of the impact
of the allostatic load caused by chronic stressors. In a recent
study, we showed that the long-term consequences of
exposure to stress leads to an imbalance in lipid homeostasis
in specific brain areas [12]. However, chronic stress also affects
many other physiological parameters. As previously men-
tioned, the response to chronic stress in the rodent involves an
increase in CORT blood levels, which partly modulates its
deleterious effects [102]. We reasoned that specific lipid
changes could potentially be correlated with CORT blood
levels [103, 104]. To further validate our hypothesis, we
performed a full-scale unbiased correlation analysis between
the abundance of over 300 quantifiable lipid species and the
serum levels of CORT, in each brain region. With such an
approach, we extended our analysis to the level of the
individual within each group. This is particularly important
Figure 2. Pathways of sphingolipid and glycerophospholipid metab-
olism. A: Brain Cer levels are increased under conditions of
stress [12, 61]. Such flux in sphingolipid metabolism is likely to occur
due to increased hydrolysis of SM by sphingomyelinases but can
also be related to increased de novo formation (enzymes highlighted
in red). To alleviate Cer burden, sphingolipid breakdown may be
reduced by pharmacological inhibition of SMases or stimulation of
both SM and glycosphingolipid synthesis (highlighted in green).
Alternatively, Cer may be hydrolized by ceramidases or phosphory-
lated to ceramide 1-phosphate by ceramide kinases. B: Glycero-
phospholipid metabolism is impaired under chronic stress with
concerted PC breakdown and increase in its metabolites LysoPC,
PA, and DAG, possibly by increased PLA, PLD, and PLC enzyme
activity, respectively (highlighted in red). Decreased PC levels have
been reported in animal models of neurodegenerative diseases and
genetic ablation of the highlighted enzymes confers protection from
synaptic and cognitive impairment. In addition, studies have shown
decreased plasma PC levels and increased cerebrospinal fluid PC
metabolites in patients with AD [115]. Abbreviations: CD, ceram-
idase; Cer, ceramide; Cer-1P, ceramide 1-phosphate; CK, ceramide
kinase; CS, ceramide synthase; DG, diacylglycerol; GalCer, galacto-
sylceramide; GCS, glucosylceramide synthase; GlcCer, glucosylcer-
amide; GlycoSL, glycosphingolipids; LacCer, lactosylceramide;
LysoPC, lysophosphatidylcholine; MG, monoacylglyceride; PA, phos-
phatidic acid; PC, phosphatidylcholine; PLA2, phospholipase A2;
PLC, phospholipase C; PLD, phospholipase D; PS, phosphatidylser-
ine; P-Choline, phospho-choline; SM, sphingomyelin; SMase, sphin-
gomyelinase; SMS, sphingomyelin synthase; Sphingosine-1P,
sphingosine-1-phosphate; TG, triacylglyceride.
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considering that individual humans and animals present
different responses to stress, hence the concept of resilience
[105]. These distinct responses to the same stimulus are linked
to specific molecular alterations and genetic susceptibility
and should be considered in studies addressing depressive-
like behaviors [106–108]. Our results reinforced the initial
findings: in the PFC, phospholipid, and sphingolipid break-
down correlated with serum CORT. Although correlation does
not imply causation, such strong coherence suggests that
these metabolic pathways are involved and possibly mediate
stress responses. Further agreement with previous studies
implicating these metabolizing enzymes in other cognitive
disorders increase the relevance of such observations [62, 76,
109]. Other appealing approaches to screen the role of lipid
imbalances in brain dyshomeostasis would be to correlate
their levels to other known biological parameters, such as
behavioral changes, electrophysiological activity, or morpho-
logical remodeling, including synaptic plasticity and neuro-
genesis. These findings should be followed by validation
studies using genetic or pharmacological approaches target-
ing lipid modulating enzymes.
Lipid signatures as biomarkers for
neurodegenerative disorders
The prevalence of neurological and psychiatric disorders is
on the rise, and brings with it a considerable economic
burden [110]. Continuous efforts have been implemented
in order to early diagnose, prevent, halt, or reverse these
disorders. Presently, it is still a major challenge to diagnose
mood disorders and to predict their disease progression and
response to therapy. Moreover, some cognitive disorders, such
as AD, still rely on post-mortem evaluation for its diagno-
sis [111]. There is thus the need to develop new diagnostic and
disease progression biomarkers. Not surprisingly, lipidomic
studies are arising as potential means to find lipid signatures
that identify specific disease states. Importantly, while it
is still unclear the biological implication of these lipid
signatures in disease physiology, their clinical relevance
arises from the reproducibility amid independent studies and
consistency between human and animal models of disease [8,
73, 78]. In the context of AD, a recent study has reported a
blood-based lipid profile for successful detection of preclinical
AD and prediction of phenoconversion to either mild
cognitive impairment (MCI) or AD within 2–3 years [112].
The untargeted metabolomics and lipidomic profiling resulted
in the identification of 10 metabolites, namely PC and
acylcarnitine species, which could be used as a diagnostic
tool. Therefore, it is now essential to extend the approach of
lipid profiling to other neurological and psychiatric diseases,
such as chronic stress associated disorders. It would be
interesting to understand whether human studies present
similar pathological signatures to the ones observed in rodent
models. For the time being, magnetic resonance imaging
spectroscopy methods have enabled non-invasive measure-
ments of choline-containing molecules, further implicating
phospholipid membrane metabolism in mood disorders, such
as schizophrenia and depression [113]. Additional studies
co-analyzing brain data with blood and CSF samples will not
only be useful in setting new diagnostic biomarkers, but
also predicting prognosis and therapy response. Given the
complexity of the lipidome in terms of lipid categories,
classes, and subclasses, only large post-processing and
integrative methods of data analysis will allow researchers
to uncover the many important roles of these highly
modulatable molecules and transform lipidomic profiling in
a routine and cost-effective procedure, readily available for
patient care.
Conclusions and outlook
Lipidomic MS methods have opened new avenues in the
analysis of biological samples. Since lipids are major
constituents of the brain, these new analytical techniques
provide new insights in the understanding of brain physiology
and pathophysiology. Lipidomic studies allow the identifica-
tion of altered lipid pathways and lipid signatures associated
with a disease state. From now on, it will be fundamental to
characterize the impact on the lipidome of genetic manipu-
lation, pharmacological modulation, or exposure to different
environmental factors, such as diet, exercise, and psychoso-
cial stressors. Since lipids are intrinsically metabolically
connected, lipidomic mappings will provide us the framework
to correctly apply lipid-modifying therapies and use lipid
signatures for diagnosis, prognosis, and therapeutic response
in a given disease state.
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